Quay Pharma has begun investing and expanding in its recently opened Deeside, North Wales facility. The new site has also undergone a successful re-inspection by the MHRA, confirming Quay’s GMP compliance. The site’s new equipment includes a state-of-the-art ion chromatography system, which the company added to support two new projects requiring specialist analytical capability. The first of the projects concerned is for a French biopharma that is developing products for severe ne...